Bionyra Pharma
PrivateLast Round
Series A
Jun 22, 2026
Total Funding Raised
$165M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionyra Pharma Comparables
Compare Bionyra Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caldera Therapeutics | 89% | |
| TriveniBio | 79% | |
| Santa Ana Therapeutics | 77% |
Bionyra Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 22, 2026 | ||||
| Seed | Aug 1, 2025 |
Bionyra Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series A |
| VIVES Partners | Series A |
| Sanofi Ventures | Series A |
| Sofinnova Partners | Series A, Seed |
| Arkin Bio Ventures | Series A |
| Jeito Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$165M round led by Jeito and Sofinnova Partners.
- Aug 1, 2025
Raised a Seed round led by Sofinnova Partners.
Bionyra Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bionyra Pharma's valuation, stock price, and market status.
Is Bionyra Pharma a public or private company?
Bionyra Pharma is a private company.
What is the current stock price of Bionyra Pharma?
Bionyra Pharma is a private company, so its shares have no public market price. Caplight tracks Bionyra Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bionyra Pharma worth (valuation)?
Valuation information for Bionyra Pharma is not publicly available.
Can I buy Bionyra Pharma stock?
Bionyra Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bionyra Pharma's last funding round?
Bionyra Pharma's most recent funding round was Series A on June 22, 2026.
Who are the main investors in Bionyra Pharma?
Key investors in Bionyra Pharma include Sofinnova Partners, Jeito Capital.
Will Bionyra Pharma IPO soon?
No public IPO plans have been announced for Bionyra Pharma.
How can I track Bionyra Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Bionyra Pharma's shares on secondary markets.